Clinical trial Recruiting at 1 site Interventional Ages 6 to 13

Modified DIMS glasses for myopia in children

Official title: Choroidal Responses to the Modified Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses

Run by The Hong Kong Polytechnic University · NCT07547072 · Data updated 2026-11-12

This study tests whether two versions of modified DIMS spectacle lenses can influence choroidal thickness and eye growth in 6- to 13-year-olds with myopia.

Quick facts

Study typeInterventional
Ages6 Years to 13 Years
SexAll
Enrollment108 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Kowloon, Hong Kong)
StatusRecruiting
StartedApril 24, 2026
Main results expectedDecember 31, 2027
Study endsFebruary 29, 2028
Registry record updatedSeptember 17, 2026
Trial IDNCT07547072 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Hong Kong Chinese children aged 6–13 with myopia between -1.00D and -5.00D, limited astigmatism, and documented myopia progression.

Probably not a fit

Children with higher astigmatism, poor binocular vision, or who do not wear lenses consistently may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children with myopia will be randomized to wear one of two modified DIMS lenses (D1 or D2) or standard single-vision lenses for daily use over 12 months. Weekly checks in the first month will monitor choroidal thickness and other eye measurements, followed by visits at 1, 6, and 12 months to track refraction and axial length. The study aims to see if the modified lenses can affect choroidal thickness and myopia progression differently than standard lenses. Cycloplegic refraction and axial length will be measured every six months. The investigation builds on prior DIMS-type optical approaches to myopia control in children and uses a randomized design to compare multiple lens types.

Why it matters

Potential benefit: If successful, the lenses could offer a safe option to slow myopia progression and inform personalized lens choices for children.

How similar studies have gone: Previous DIMS-based approaches have shown promise in slowing myopia progression in children, but performance can vary by individual.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hong Kong Chinese
* Age at enrolment: 6 - 13 years
* Myopia in spherical power: -1.00D to -5.00D in both eyes
* Astigmatism: equal or less than 2.00D
* The sum of spherical power and astigmatism: equal or less than -7.00D
* Anisometropia (spherical equivalent refraction (SER)): equal or less than 1.50D
* Previous myopia progression (valid documentation dated within 2 years before screening):

  * -0.50D (SER) per year or more in both eyes OR Axial length elongation: 0.27mm/year in both eyes
  * If myopia is initially detected during screening, eligibility requires myopia (in SER) below the 3rd percentile curve of refraction in both eyes.12
* Best corrected visual acuity: LogMAR 0.04 or better in both eyes
* Ocular health: no abnormalities in both internal and external ocular health
* Binocular vision: no strabismus and other binocular abnormalities
* Normal colour vision
* Willing to wear the study spectacles all the time (10 hours per day, for 7 days per week)

Exclusion Criteria:

* Previous or current treatment for myopia control (e.g., red-light therapy, atropine, orthokeratology, specialized spectacle lenses and contact lenses and oral supplements for myopic control)
* Existing or past eye diseases or surgeries (e.g., strabismus surgery, amblyopia, oculomotor nerve palsies, corneal disease, intraocular disease, etc.) that may have an impact on vision or visual development
* Long-term medication (intake at least 3 days/week) or medication/supplements that affect eye health
* Systemic diseases that may have an impact on vision or visual development (e.g., endocrine, cardiac and respiratory diseases, diabetes, Down syndrome, etc.)
* Allergic to cyclopentolate eye drops
* Individuals who, in the judgment of the Investigator, are unable to cooperate and follow instructions during eye examination.

Where it's running

  • Optometry Research Clinic, School of Optometry, The Hong Kong Polytechnic University
    Kowloon, Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Rachel Ka Man Chun, PhD — School of Optometry, The Hong Kong Polytechnic University
  • Study coordinator: Rachel Ka Man Chun, PhD
  • Email: rachel.chun@polyu.edu.hk
  • Phone: 852-27664224

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.